Geir Christian Enli Mordal (f. 1975) er spesialist i indremedisin og i nyresykdommer og arbeider som overlege.
Forfatter har fylt ut ICMJE-skjemaet og oppgir ingen interessekonflikter.
Nyremedisinsk avdeling
Akershus universitetssykehus
()
1.
DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173 – 94. [PubMed] [CrossRef]
2.
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366: 539 – 51. [PubMed] [CrossRef]
3.
Rose NR. Predictors of autoimmune disease: autoantibodies and beyond. Autoimmunity 2008; 41: 419 – 28. [PubMed] [CrossRef]
4.
Liaño F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Kidney Int 1996; 50: 811 – 8. [PubMed] [CrossRef]
5.
Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365: 417 – 30. [PubMed] [CrossRef]
6.
Duong JK, Furlong TJ, Roberts DM et al. The role of metformin-associated lactic acidosis (MALA): Case series and formulation of a model of pathogenesis. Drug Saf 2013; 36: 733 – 46. [PubMed] [CrossRef]
7.
Bird HA, Esselinckx W, Dixon AS et al. An evaluFation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434 – 9. [PubMed] [CrossRef]
8.
Bitik B, Mercan R, Tufan A et al. Differential diagnosis of elevated erythrocyte sedimentation rate and C-reactive protein levels: a rheumatology perspective. Eur J Rheumatol 2015; 2: 131 – 4. [PubMed] [CrossRef]
9.
Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 2010; 126: 39 – 44. [PubMed] [CrossRef]
10.
Hartmann A, Jenssen T, Julsrud J. Vanlige presentasjonsformer av nyresykdom. I: Hartmann A, Jenssen T, Julsrud J. Nyremedisin – en praktisk veileder. Oslo: Gyldendal Akademisk, 2008: 13 – 58.
11.
Saeki T, Ito T, Yamazaki H et al. Hypocomplementemia of unknown etiology: an opportunity to find cases of IgG4-positive multi-organ lymphoproliferative syndrome. Rheumatol Int 2009; 30: 99 – 103. [PubMed] [CrossRef]
12.
Clarkson MR, Giblin L, O'Connell FP et al. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 2004; 19: 2778 – 83. [PubMed] [CrossRef]
13.
Guma M, Firestein GS. IgG4-related diseases. Best Pract Res Clin Rheumatol 2012; 26: 425 – 38. [PubMed] [CrossRef]
14.
Kamisawa T, Takuma K, Egawa N et al. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol 2010; 7: 401 – 9. [PubMed] [CrossRef]
15.
Kamisawa T, Zen Y, Pillai S et al. IgG4-related disease. Lancet 2015; 385: 1460 – 71. [PubMed] [CrossRef]
16.
Deshpande V, Zen Y, Chan JK et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25: 1181 – 92. [PubMed] [CrossRef]
17.
Harreby M, Bilde T, Helin P et al. Retroperitoneal fibrosis treated with methylprednisolon pulse and disease-modifying antirheumatic drugs. Scand J Urol Nephrol 1994; 28: 237 – 42. [PubMed]
18.
Neild GH, Rodriguez-Justo M, Wall C et al. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 2006; 4: 23. [PubMed] [CrossRef]
19.
Khosroshahi A, Carruthers MN, Stone JH et al. Rethinking Ormond's disease: «idiopathic» retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) 2013; 92: 82 – 91. [PubMed] [CrossRef]
Kommentarer
( 0 )
Dette kommentarfeltet modereres, men kommentarer blir ikke redaksjonelt behandlet ut over å sikre at de følger retningslinjer for vårt kommentarfelt.
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.
Publisert: 22. november 2016
Utgave 21, 22. november 2016
Tidsskr Nor Legeforen 22. november 2016
doi:
10.4045/tidsskr.16.0206
Mottatt 4.3. 2016, første revisjon innsendt 30.6. 2016, godkjent 6.9. 2016. Redaktør: Tor Rosness.
Får du ikke vist PDF-filen eller vil lagre filen, kan du høyreklikke på PDF-ikonet. Velg «Lagre mål/fil som..» og hent så opp PDF-filen i for eksempel Acrobat Reader.